Olympus had 25 patents in artificial intelligence during Q1 2024. Olympus Corp filed patents in Q1 2024 for systems and methods related to imaging and treating tissue internally in human or animal subjects. These patents include technologies such as image processing for identifying bleeding positions during surgery, estimating thermal invasion in living tissue during energy treatment, delivering laser energy to target tissue using spectroscopic feedback, and generating learning data for neural networks. GlobalData’s report on Olympus gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Olympus grant share with artificial intelligence as a theme is 60% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Tissue therapy energy delivery using optical imaging (Patent ID: US20240099763A1)
The patent filed by Olympus Corp describes a system for imaging and treating tissue that includes an imaging sensor, tissue therapy output, and controller circuitry. The system utilizes signal-processing circuitry to process imaging information from inside a human or animal subject to determine tissue characteristics and adjust parameters controlling the tissue therapy output accordingly. The system can recognize features from tissue images, adjust clamping force, modulate energy characteristics, and provide user alerts based on the imaging information.
The system also includes an end effector with a jaw assembly for tissue therapy application, where the controller circuitry can establish or adjust the target clamping force based on imaging information. Additionally, the system can modulate electrosurgical energy signals, recognize features like tissue width or vessel diameter, and determine contact area of compressed tissue. The controller circuitry is further configured to tailor tissue therapy compression force parameters based on imaging information, including using a camera for visualization, and can control the tissue therapy output based on information from an electrical tissue characteristic sensor. Overall, the system combines imaging and treatment capabilities to provide precise and tailored tissue therapy based on internal imaging information.
To know more about GlobalData’s detailed insights on Olympus, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
